Suppr超能文献

维生素 D 缺乏与住院 COVID-19 患者临床结局的关系。

The association between vitamin D deficiency and the clinical outcomes of hospitalized COVID-19 patients.

机构信息

Division of Hematology and Oncology, Department of Internal Medicine, Dr. Cipto Mangunkusumo National Referral Hospital, Faculty of Medicine, Universitas Indonesia, Centra Jakarta, DKI Jakarta, 10430, Indonesia.

Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Central Jakarta, DKI Jakarta, 10430, Indonesia.

出版信息

F1000Res. 2024 Feb 5;12:394. doi: 10.12688/f1000research.132214.3. eCollection 2023.

Abstract

BACKGROUND

Vitamin D deficiency is an emerging public health problem that affects more than one billion people worldwide. Vitamin D has been shown to be effective in preventing and reducing the severity of viral respiratory diseases, including influenza. However, the role of vitamin D in COVID-19 infection remains controversial. This study aimed to analyze the association of vitamin D deficiency on the clinical outcome of hospitalized COVID-19 patients.

METHODS

A prospective cohort study was conducted among hospitalized COVID-19 patients at two COVID-19 referral hospitals in Indonesia from October 2021 until February 2022.

RESULTS

The median serum 25(OH)D level in 191 hospitalized COVID-19 patients was 13.6 [IQR=10.98] ng/mL. The serum 25(OH)D levels were significantly lower among COVID-19 patients with vitamin D deficiency who had cardiovascular disease (p-value=0.04), the use of a ventilator (p-value=0.004), more severe COVID-19 cases (p-value=0.047), and mortality (p-value=0.002). Furthermore, serum 25(OH)D levels were significantly different between patients with mild and severe COVID-19 cases (p-value=0.019). Serum 25(OH)D levels in moderate and severe COVID-19 cases were significantly different (p-value=0.031). Lower serum 25(OH)D levels were significantly associated with an increased number of comorbidities (p-value=0.03), the severity of COVID-19 (p-value=0.002), and the use of mechanical ventilation (p-value=0.032). Mortality was found in 7.3% of patients with deficient vitamin D levels. However, patients with either sufficient or insufficient vitamin D levels did not develop mortality.

CONCLUSIONS

COVID-19 patients with vitamin D deficiency were significantly associated with having cardiovascular disease, mortality, more severe COVID-19 cases, and the used of mechanical ventilation. Lower serum 25(OH)D levels were associated with an increased number of comorbidities, COVID-19 severity, and the use of mechanical-ventilation. Thus, we suggest hospitalized COVID-19 patients to reach a sufficient vitamin D status to improve the clinical outcome of the disease.

摘要

背景

维生素 D 缺乏是一个全球性的公共卫生问题,影响着全球超过 10 亿人。维生素 D 已被证明可有效预防和减轻病毒性呼吸道疾病(包括流感)的严重程度。然而,维生素 D 在 COVID-19 感染中的作用仍存在争议。本研究旨在分析维生素 D 缺乏与住院 COVID-19 患者临床结局的关系。

方法

这是一项在印度尼西亚两家 COVID-19 转诊医院进行的住院 COVID-19 患者的前瞻性队列研究。

结果

191 名住院 COVID-19 患者的中位血清 25(OH)D 水平为 13.6 [IQR=10.98]ng/mL。维生素 D 缺乏的 COVID-19 患者中,患有心血管疾病(p 值=0.04)、使用呼吸机(p 值=0.004)、COVID-19 病情更严重(p 值=0.047)和死亡率(p 值=0.002)的患者血清 25(OH)D 水平显著较低。此外,血清 25(OH)D 水平在轻度和重度 COVID-19 病例之间存在显著差异(p 值=0.019)。中度和重度 COVID-19 病例的血清 25(OH)D 水平有显著差异(p 值=0.031)。较低的血清 25(OH)D 水平与合并症数量的增加(p 值=0.03)、COVID-19 严重程度(p 值=0.002)和机械通气的使用(p 值=0.032)显著相关。缺乏维生素 D 的患者中有 7.3%出现死亡。然而,血清维生素 D 水平充足或不足的患者并未出现死亡。

结论

维生素 D 缺乏的 COVID-19 患者与患有心血管疾病、死亡率、更严重的 COVID-19 病例以及使用机械通气显著相关。较低的血清 25(OH)D 水平与合并症数量增加、COVID-19 严重程度和机械通气的使用相关。因此,我们建议住院 COVID-19 患者达到足够的维生素 D 状态,以改善疾病的临床结局。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4274/10964975/17612cd5b888/f1000research-12-162135-g0000.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验